Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Allogeneic human dermal fibroblasts

EU orphan designation number: EU/3/10/774   
Active ingredient: Allogeneic human dermal fibroblasts
Indication: Treatment of epidermolysis bullosa
Sponsor: Intercytex Ltd
Core Technology Facility, 46 Grafton Street, Manchester M13 9NT, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/09/2010 Orphan designation EMA/OD/061/09 (2010)6641 of 20/09/2010
9/11/2010 Change of name and/or address of sponsor EMA/600625/2010
19/01/2012 Change of name and/or address of sponsor EMEA/OD/061/09